
Discusses all aspects of novel and emerging therapies for myeloma and other plasma cell neoplasms
Includes new diagnostic criteria for multiple myeloma
Presents recently acquired data relating to prognosis and minimal residual disease
Nous publions uniquement les avis qui respectent les conditions requises. Consultez nos conditions pour les avis.